Proteasomal degradation of core protein variants from chronic hepatitis B patients

Sabine Braun1, Anna Zajakina, Jekaterina Aleksejeva

  • 1Universitätsmedizin Berlin, Charité, Institut für Virologie, Campus Mitte, Charitéplatz 1, Berlin, Germany.

Insights

Hepatitis B virus (HBV) variants with C gene deletions in transplant patients show lower core protein levels and faster degradation. This proteasomal pathway involvement impacts HBV infection severity and end-stage liver disease progression.

Area of Science:

  • Virology
  • Immunology
  • Hepatology

Background:

  • Hepatitis B virus (HBV) variants with internal C gene deletions are linked to severe infections and end-stage liver disease (ESLD) in immunosuppressed renal transplant recipients.
  • Understanding the behavior of these HBV variants is crucial for managing infection in vulnerable patient populations.

Purpose of the Study:

  • To investigate the synthesis and proteasomal degradation of HBV core (HBc) protein variants with internal in-frame deletions.
  • To compare the stability and turnover of these deletion variants with wild-type HBc protein.

Main Methods:

  • Expression of six HBV C genes with internal in-frame deletions in two eukaryotic cell lines.
  • Comparison of steady-state levels and proteasomal degradation rates of wild-type HBc and deletion variant HBc proteins.

Main Results:

  • Internally deleted HBc proteins, especially those with longer deletions, exhibited considerably lower steady-state levels compared to wild-type HBc.
  • Deletion variants demonstrated significantly higher turnover rates, being rapidly degraded via the proteasome pathway.

Conclusions:

  • Proteasomal degradation plays a significant role in the turnover of HBc protein variants with internal deletions.
  • The rapid degradation of these variants may influence the clinical course of HBV infection in immunosuppressed patients.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...